Delivery Order SPE2DR25D2014-SPE2DR26FZ89L
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $3,846.63 for Glimepiride 4 mg tablets (100-count units) on April 30, 2025, with an ultimate completion date of May 1, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Glimepiride 4 mg tablets in quantities of 100 units at a ceiling value of $1,606.70. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 19,...
- The Defense Logistics Agency awarded a $2,977.70 delivery order to AmerisourceBergen Drug Corp for Glimepiride 4 mg tablets (100-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This non-competitive, firm fixed-price delivery order was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $1,960.24 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a medication commonly prescribed for type 2 diabetes management. This is a firm fixed-price, non-set-aside contract awarded on November 18, 2025, with completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,784.23 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a generic medication commonly used in diabetes management. This firm fixed price, competitively awarded delivery order was finalized on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $2,968.93 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) under a firm fixed price contract. The award, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive procurement. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,157.52 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,799.68 to AmerisourceBergen Drug Corp for Glimepiride 1 mg tablets in quantities of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Glimepiride is an oral medication used in the...
- The Defense Logistics Agency awarded a $18,928.67 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a generic oral medication commonly prescribed for type 2 diabetes management. This firm fixed price contract, awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, is a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ89LDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,130.48 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Glimepiride 4 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside procurement. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen routinely fulfills delivery orders for generic and brand-name medications through its DLA contract vehicle. Glimepiride, a diabetes management medication, represents the type of therapeutic pharmaceutical product the company regularly supplies to Defense Health Agency systems and other federal healthcare customers. This delivery order exemplifies the company's role as a primary supplier within the DLA's pharmaceutical supply chain, supporting military medical readiness through efficient and competitive pharmaceutical procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/4/25 |